Tiragolumab, CISPLATIN , Tecentriq 1 200 mg concentrate for solution for infusion, GEMCITABINE clinical trials

A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients with Urothelial Carcinoma (MORPHEUS-UC)

This study, called MORPHEUS-UC, is testing new combinations of medicines for bladder cancer. It looks at how well these treatments shrink tumours or make them disappear, and also checks for any side effects. It's an early-stage study involving people with this type of cancer.